Welcome to Last Minute Lecture.
This free chapter overview is designed to help students review and understand key concepts.
These summaries supplement not replaced the original textbook and may not be redistributed or resold.
For complete coverage, always consult the official text.
Welcome back to The Deep Dive.
Today we are tackling Chapter 20 from Focus on Nursing Pharmacology.
We're going deep on anxiolytic and hypnotic agents that a really critical class of that depress the central nervous system.
Exactly.
And our mission here is to really cut through the dense clinical data and pull out what you actually need to know.
We need to define these drugs, understand how the major classes, you know, the benzodiazepines and barbiturates actually work.
And more importantly, distill those key safety alerts, the nursing considerations that turn just, you know, information into safe patient care.
Absolutely.
When you're talking about medications that are controlling things like sleep, anxiety, the margin for error is just so small.
It really is.
You have to know the names, of course, but also the crucial safety points, especially around metabolism and interactions.
So to start, let's frame the conditions we're even talking about.
These drugs treat really three main states.
Okay, so first up is anxiety.
Right.
Anxiety, that feeling of tension, of fear that's, well, when it's severe, it can stop someone from doing even basic things.
Right.
And then comes sedation.
Sedation is a loss of awareness, a loss of reaction to what's going on around you.
It can be calming, but it brings that drowsiness with it.
Which might be what you want for a really restless patient.
It could be.
And then if you push that sedation to its extreme, you get hypnosis.
So that's deep CNS depression, really designed to induce sleep.
We're talking about acting on the reticular activating system, the RAS.
Exactly.
Hypnotics act to block the brain's ability to even respond to outside stimuli.
So if you think of your brain as having like a volume dial.
Yeah, that's a great way to put it.
Anxiolytics are turning down the volume on fear.
Sedatives turn down the overall awareness.
And hypnotics are just hitting the mute button.
That's it.
And historically, a lot of the older drugs, they did all three of these things just by upping the dose.
The only difference was how much you took.
Okay.
So let's get into the modern solution, the most frequently used class today.
The benzodiazepines.
Why did these become the standard?
Well, because they manage anxiety without that really heavy sedation.
And they have a much lower risk of physical dependence compared to the older drugs.
And their mechanism is much more targeted.
Beautifully targeted.
They work in the limbic system and the RAS, but they don't work alone.
They boost the effect of a natural compound in your brain.
GABA.
GABA.
Gamma aminobutyric acid.
That's the brain's main pedal.
It's primary inhibitory neurotransmitter.
Precisely.
So benzodiazepines, they don't replace the brake pedal.
They just make it much more sensitive, more effective.
So they're potentiating GABA interfering with neuron firing.
And the result is you get that desired calming effect at doses far lower than what you'd need to, you know, put the whole brain to sleep.
Which is why they're so good for anxiety disorders, alcohol withdrawal, that kind of thing.
Exactly.
And for anxiety relief.
Now, practically speaking, they absorb quickly, but their metabolism,
that carries some really big warnings.
It does.
They're metabolized extensively in the liver.
So if your patient has liver disease, you have to reduce that dose drastically.
And they're lipid soluble, which means they cross the placenta.
Cross the placenta, enter breast milk.
That makes them a major contraindication in pregnancy.
We see associations with things like
cardiac defects.
And this brings us to the big one.
The one you absolutely cannot miss.
The black box warning.
Yes.
If you use benzodiazepines at the same time as opioids, the risk of profound sedation, respiratory depression, coma, and even death, it skyrockets.
It's non -negotiable.
You have to use extreme caution.
And we also have to talk about a vital cultural consideration here.
The source material points out that up to 20 % of African American patients have a genetic predisposition to metabolize these drugs more slowly.
Okay.
So delayed metabolism.
What does that mean for the patient in the chair?
It means the drug hangs around longer.
A standard dose can act like a much higher dose, increasing the risk for really severe adverse effects over sedation.
Well, the takeaway is you have to start with the absolute smallest possible dose and you monitor them meticulously, especially in that first week.
This is what individualized care really looks like.
When we look at the adverse effects, beyond the drowsiness you'd expect,
there's this really serious warning about complex behaviors.
They mention sleep driving.
Yeah, sleep driving, making food, having conversations,
things the patient has zero memory of later.
It's a kind of dissociative state.
It's a severe adverse effect.
And of course, you can't just stop them cold turkey.
No, abrupt cessation is dangerous.
It can trigger a withdrawal syndrome, nausea, vertigo, and even seizures.
The prototype here is Diazepam or Valium.
It's known for that incredibly long half -life, right?
20 to 80 hours.
That's the one.
And one more crucial safety point for this whole class.
Never, ever administer them intra arterially.
Why not?
Immediate risk of arteriospasm and gangrene.
It's an absolute contraindication.
Okay.
So now that we get the modern mainstay, let's look back at the historical heavyweights, the barbiturates.
Why did we
Simply put, they're much more dangerous.
The risk of addiction, dependence, severe side effects.
It's just significantly higher.
But they're still around.
Phenobarbital is still used.
It is, yeah.
But mostly for seizure treatment, pre -anesthesia,
very specific indications now.
Not really for general anxiety anymore.
And what's the difference in how they work?
Well, while Bensa's potentiate GABA, barbiturates are just general CNS depressants.
They work broadly inhibiting the RAS, depressing the cerebral cortex.
So they don't just tune the brain down.
They shut the whole system down.
That's a good way to see it.
It's a much blunter instrument.
And that lets them cause everything from mild sedation all the way up to a deep coma.
But the most critical difference, the thing that every nurse needs to understand is what they do to the liver.
Let's talk about enzyme induction.
This is a huge synthesis point for you.
Barbiturates are notorious for inducing the breaking down drugs.
They put it into overdrive.
Think of those enzymes as a cleanup crew.
Barbiturates don't just call in the crew.
They hire 100 extra workers, and those workers start clearing out everything.
Not just the barbiture itself.
No, everything that's metabolized by that system.
So if your patient is on, say, oral contraceptives.
The barbiturate speeds up the birth control's destruction.
And you can get contraceptive failure.
Same thing for drugs like digoxin or anticoagulants.
Their effectiveness just plummets.
It's a fundamental difference from the benzos, which don't cause this.
I mean, adverse effects are severe.
Respiratory depression, laryngospasm.
And potentially fatal hypersensitivity reactions like Stevens -Johnson syndrome.
And that same warning applies here.
Do not administer intraarterially.
Okay, let's pivot to some of the other ages, some more specialized ones.
Right.
First one to highlight is buspirone.
It's an anxiolytic, but what's so fascinating is that it has none of these sedative, anticonvulsant, or muscle relaxant properties of the benzos.
So it's for anxiety, but it won't make you drowsy.
Exactly.
If your patient needs to stay fully alert for their job or just their life, buspirone is often a much better choice.
Then you have the newer hypnotics, like zolpidem, and they carry that same sleep driving warning we talked about earlier.
They do.
And then there are two newer classes that target natural sleep processes.
First, the melatonin receptor agonists like aramaltin.
And they work on the receptors for your circadian rhythm.
Yep.
Great for people who have trouble falling asleep.
And the newest player on the block is an orexin receptor antagonist, suverexant.
So orexin is a chemical in your brain that actively promotes wakefulness.
Suverexant blocks that signal.
It suppresses the drive to wake up.
That sounds powerful.
It is.
And the safety warning is strict.
The patient has to be in bed within 30 minutes of taking it.
And they must plan to stay there for at least seven hours.
Okay.
This is a ton of pharmacology.
We have to translate this into practical care.
Let's talk about nursing considerations across the lifespan.
The response to these drugs is so age dependent.
In children, for example, the response can be totally unpredictable.
You might see aggression or irritability instead of calm.
So what do we use?
Often older agents like antihistamines are used, but the dosage has to be calculated so carefully and you have to monitor their breathing.
And for the typical adult patient.
The message is always short -term use only.
This is a temporary aid, not a solution.
The real focus has to be on non -drug measures.
Good sleep hygiene, therapy, addressing the root cause.
And then for older adults, they're the most vulnerable group.
Highly susceptible.
They get more dizziness, more sedation, higher risk of falls, even hallucinations.
The dose has to be reduced and you have to monitor their baseline liver and renal function.
Safety is just, it's paramount.
Let's go back to something you said earlier, the danger of rapid 5E administration.
Why is that so risky?
Because the effects are almost immediate.
Pushing an IV benzodiazepine or barbiturate too quickly can cause severe hypotension, bradycardia, even cardiac arrest.
So you have to go slow.
Very slow.
And if it's a parenteral benzo, the patient needs to stay in bed for at least three hours after you give it.
And for anyone who's been on these long -term.
Tapering is mandatory.
You cannot just stop them.
You have to reduce the dose gradually to prevent withdrawal syndrome, which can include seizures.
Okay.
Let's use the critical thinking scenario from the source to tie this all together.
PP, a 43 year old dealing with stress is prescribed diazepam.
What's the lesson there?
Her case really highlights that the drug is only one piece of the puzzle.
The diazepam gives her immediate relief.
It's like a splint for a crisis.
But it's not fixing the underlying problem.
Not at all.
The core issues need non -drug interventions.
Counseling, support groups, new coping mechanisms.
If we just give the pill without that support, we are failing the patient.
So to wrap up, here are the essential takeaways for you.
Benzodiazepines potentiate GABA.
They make the brains break petals stronger.
But that combination with opioids is a deadly black box warning.
And barbiturates are those broad CNS depressants, infamous for inducing liver enzymes, which can make other crucial drugs like birth control completely ineffective.
And remember that this knowledge has to be individualized.
Understanding things like enzyme induction or that delayed genetic metabolism in some African -American patients.
That is what elevates your care.
It's what takes you from just following an order to providing truly personalized, safe and effective interventions.
Always be curious about the why behind drug metabolism and how those little individual differences can change absolutely everything.
We hope this deep dive has given you the clarity you need for this very challenging part of pharmacology.
We'll see you next time.